accounta collaboration agreement with Biogen Idec Inc for the multiple sclerosis drug Tysabri in making a deal with Johnson & Johnson , a U.S. judge ruled Thursday. Manhattan federal court judge Deborah Batts said Elan has until Sept. 26 to repair the breach in...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to US judge finds Elan breached agreement with Biogen
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account